Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-10
1989-09-19
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544296, 544333, A61K 31505
Patent
active
048681857
ABSTRACT:
Certain trans-6-[[(substituted)pyrimidin-5-yl]ethyl]- and ethenyl]tetrahydro-4-hydroxypyran-2-ones and the corresponding dihydroxy ring-opened acids derived therefrom are potent inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) and are useful as hypocholesterolemic and hypolipidemic agents.
REFERENCES:
patent: 4613610 (1986-09-01), Wareing
patent: 4647576 (1987-03-01), Hoefle et al.
patent: 4668794 (1987-05-01), Wareing
patent: 4681893 (1987-07-01), Roth
Chucholowski Alexander W.
Roth Bruce D.
Sliskovic Drago R.
Daignault Ronald A.
Lee Mary C.
Northington Zinna
Warner-Lambert & Company
LandOfFree
6-[[Substituted)pyrimidinyl)ethyl]- and ethenyl]tetrahydro-4-hyd does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-[[Substituted)pyrimidinyl)ethyl]- and ethenyl]tetrahydro-4-hyd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-[[Substituted)pyrimidinyl)ethyl]- and ethenyl]tetrahydro-4-hyd will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-368894